Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04667598

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
  • Jun Li Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04667598
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04667598. Randomized; no masking; primary purpose treatment. Start 2020-12-15 (anticipated); primary completion 2022-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical and Metabonomics Study on the Treatment of Heart Failure After Myocardial Infarction With Modified Wenxin Decoction
Condition
Heart Failure
Intervention (Drug)
Modified Wenxin Decoction
Lead sponsor
Jun Li (class: other)

Record details

Record id
cardio:ct-nct04667598
Content hash
349a4ed5de2a2a15b791e5b7f2e5520738678299b4b35664a838eb2017795dac